Corbus Pharmaceuticals Holdings Inc. Stock Sheds 7.2%, Underperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. shed 7.2% to $3.92 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,983.98 and the NASDAQ Composite Index falling 1.1% to 25,164.32.

Corbus Pharmaceuticals Holdings Inc. closed 69.6% short of its 52-week high of $12.88, which the company achieved on May 22nd.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. rose 2.4% to $3.88, Fortress Biotech Inc. rose 0.5% to $1.93, and Viking Therapeutics Inc. fell 1.65% to $26.83.

Trading volume totaled 672,978, compared to the 50-day average of 1.1 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

November 02, 2026 16:34 ET (21:34 GMT)